Main Navigation

Mercia
  • Ventures
  • Debt
  • Private equity
  • Team
  • Contact us
  • About us
  • Investment strategies
  • Investor area
    • PLC
    • EIS
    • VCT
  • Contact us

Audience

|

Change

  • Ventures
  • Debt
  • Private equity
  • Team
  • Contact us
  • About us
    • About us
      • Our history
      • Our vision and values
      • University partnerships
    • Team
    • Careers
    • Portfolio
    • Sustainability
  • Strategies
    • Our investment strategy
      • Our funds
    • Strategic assets
    • Property development finance
    • EIS & VCT
  • For shareholders
    • Share price
    • Board of directors
    • Financial reports & presentations
    • Regulatory news
    • Corporate governance
    • AIM Rule 26
    • Organisational structure
    • Annual Report
    • VCT
      • Northern Venture Trust
      • Northern 2 VCT
      • Northern 3 VCT
  • Insights & Research
    • Hub
  • Ventures
  • Debt
  • Private equity
  • Team
  • Contact us
  • About us
  • Investment strategies
  • Investor area
    • PLC
    • EIS
    • VCT
  • Contact us
  • About us
    • About us
      • Our history
      • Our vision and values
      • University partnerships
    • Team
    • Careers
    • Portfolio
    • Sustainability
  • Strategies
    • Our investment strategy
      • Our funds
    • Strategic assets
    • Property development finance
    • EIS & VCT
  • For shareholders
    • Share price
    • Board of directors
    • Financial reports & presentations
    • Regulatory news
    • Corporate governance
    • AIM Rule 26
    • Organisational structure
    • Annual Report
    • VCT
      • Northern Venture Trust
      • Northern 2 VCT
      • Northern 3 VCT
  • Insights & Research
    • Hub

Announcements

Commercialising university IP (tax) efficiently
Leicester spinout MIP Diagnostics appoints CEO
Investment support for technology-backed or knowledge-intensive businesses
How digital platforms will revolutionise the trading card industry
The Native Antigen Company launches new e-commerce platform for underserved antigen sector
NuVision becomes first University of Nottingham spinout to receive seed funding from Mercia
The Mercia Group Quarterly: Ambition
Finalists announced for inaugural Growth Investor Awards
Mercia Technologies backs Fractured Space developer with first investment
Mercia continues long-standing support of home care technology company, Canary Care
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • Next
Loading...
Loading...

Disclaimer

Which of these options best describes you?

Please wait...
Accept

Disclaimers

Which of these options best describes you?

Please wait...
Accept

© 2026 Mercia Asset Management

  • Contact us
  • Privacy policy
  • Terms and conditions
  • Modern Slavery Statement
  • Diversity, Equity & Inclusion Policy
  • Sustainability

Mercia Asset Management PLC is registered in England and Wales: 09223445. Its subsidiaries, Mercia Fund Management Limited, Mercia Regional Ventures Limited, Mercia Business Loans Limited and Frontier Development Capital Limited are authorised and regulated by the Financial Conduct Authority.

Loading...
Loading...

Disclaimer

Which of these options best describes you?

Please wait...
Accept

Disclaimers

Which of these options best describes you?

Please wait...
Accept